🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Low

TP-03

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions, with a lead product candidate TP-03 for blepharitis treatment.

Tags: Demodex mites, biopharmaceutical, blepharitis, ophthalmic conditions, therapeutic candidates

Symbol: TARS

Recent Price: $54.70

Industry: Biotechnology

CEO: Dr. Bobak R. Azamian M.D.

Sector: Healthcare

Employees: 244

Address: 15440 Laguna Canyon Road, Irvine, CA 92618

Phone: 949 409 9820

Leadership

  • Bobak Azamian, MD, PhD, Chief Executive Officer and Chairman
  • Jeff Farrow, Chief Financial Officer and Chief Strategy Officer
  • Aziz Mottiwala, Chief Commercial Officer
  • Sesha Neervannan, PhD, Chief Operating Officer
  • Bryan Wahl, MD, JD, General Counsel
  • Dianne Whitfield, Chief Human Resources Officer
  • Cara Miller, SVP, Corporate Affairs
  • Bhaskar Chaudhuri, PhD, Director
  • Rosemary Crane, Director
  • Andrew Goldberg, MD, Director
  • William J. Link, PhD, Director
  • Scott Morrison, Director
  • Wendy Yarno, Director and Lead Independent Director
  • Elizabeth Yeu, MD, Director and Chief Medical Advisor

Last updated: 2024-12-31